News | Lung Imaging | April 29, 2019

Physicians, Patients Talking Less About Lung Cancer Screening

Study also finds that when discussions are had, they do not appear to impact screening rates

Physicians, Patients Talking Less About Lung Cancer Screening

April 29, 2019 — Smoking rates are down nationally, but so are discussions among physicians and smokers about lung cancer screening, University of Florida researchers have found. However, the study also found these patient-physician conversations did not affect current smokers’ intent or attempts to quit.

Lung cancer is the leading cause of cancer-related death in the United States. For active smokers, lung cancer screening can reduce cancer-related mortality by 20 percent. But the study found screening may have no benefits for individuals who do not smoke frequently or are younger than 55 years old, the recommended age to start yearly screenings.

The researchers expected to find that if patients who smoke engage in a discussion about lung cancer screening with their physicians, they will be more motivated to quit. However, the study showed physician-patient discussions were not associated with any changes in smokers’ behavior.

These results are surprising because we actually want to see an increase in this discussion among smokers who have a high risk of lung cancer, and for this discussion to modify patients’ smoking behavior,” said Jinhai “Stephen” Huo, Ph.D., M.D., Ms.PH., an assistant professor at the UF College of Public Health and Health Professions’ department of health services research, management and policy, and the study’s principal investigator.

Patients who are at a high risk of developing lung cancer have a history of heavy smoking, either currently smoke or have quit within the past 15 years, and are between the age 55 and 77 years old. All others are considered low risk and are not eligible for lung cancer screening.

Patient-physician discussions are an opportunity to persuade current smokers to modify or abandon their smoking habits, said Huo. Study data, however, showed that receiving a lung cancer screening did not significantly impact the desire to quit smoking, also called smoking cessation. This suggests that a simple discussion or being screened may not build lasting motivation for current smokers to quit or modify their smoking habits.

The study also found the rates of discussions about lung cancer screenings between physicians and patients who smoke or have a history of smoking decreased from 6.7 percent in 2012 to 4.2 percent in 2014 and 4.3 percent in 2017 — three years that followed a national event promoting lung cancer screening.

Huo and his colleagues also found significant variation exists in the rate of discussion about lung cancer screening. For example, among current smokers, non-Hispanic blacks, Hispanics, patients covered by insurance, and those diagnosed with heart or lung disease were more likely to discuss lung cancer screening with their physicians.

Screening for lung cancer is done using low-dose computed tomography (CT) scan, in which an X-ray machine scans the body and uses low doses of radiation to make detailed pictures of the lungs. The U.S. Preventive Services Task Force only recommends yearly lung cancer screening for people who have a history of heavy smoking, smoke now or have quit within the past 15 years, and are between 55 and 80 years old. This is because lung cancer screening has risks, including exposure to radiation. It can involve invasive diagnostic procedures and may increase the risk of post-procedural complications and related costs.

“Cancer screenings are beneficial based on two clinical trials only to a subgroup of patients,” said Huo. “We recommend that patients have an in-depth discussion with their physician, going over the benefits and harms of the lung cancer screening.”

These findings show that lung cancer screenings are underused and not reaching the smokers who have high risk of lung cancer who would benefit the most from it. This information could inform policymakers and practitioners on emphasizing the importance of shared decision-making among patients and their physicians, said Huo.

According to the study, the burden of lung cancer will be reduced by developing communication strategies for promoting beneficial lung cancer screenings among those who are eligible and strategies for improving the quality of these discussions.

“Physicians should let smokers know that lung cancer screening using a low-dose CT scan is not an alternative to smoking cessation, and make smoking cessation resources available for all smokers during the discussion about lung cancer screening,” said Huo.

For the study, Huo and his colleagues analyzed data from the National Cancer Institute’s Health Information National Trends Survey (HINTS) in 2012, 2014 and 2017 — which altogether included 9,433 respondents. In 2011, the National Lung Screening Trial, the largest trial of lung cancer screening ever conducted, demonstrated that low-dose CT scans reduced lung cancer mortality by 20 percent. In 2013, the United States Preventive Services Task Force issued a recommendation for annual lung cancer screening for those who meet certain criteria. In 2015, the Centers for Medicare & Medicaid Services released a lung cancer screening Medicare policy.

Huo’s study, which was published in the journal Cancer Epidemiology, Biomarkers & Prevention,1 a journal of the American Association for Cancer Research, was supported by the University of Florida Health Cancer Center Research Pilot Grant through the Florida Consortium of National Cancer Institute Centers Program at the University of Florida.

For more information: www.cebp.aacrjournals.org

Reference

1. Huo J., Hong Y-R, Bian J., et al. Low Rates of Patient-Reported Physician–Patient Discussion about Lung Cancer Screening among Current Smokers: Data from Health Information National Trends Survey. Cancer Epidemiology, Biomarkers & Prevention, published online April 25, 2019. DOI: 10.1158/1055-9965.EPI-18-0629

Related Content

AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...
The use of CT and X-ray in the assessment and treatment plan for President Trump underscores the critical role that medical imaging must play in the fight against COVID-19

A COVID-19 chest CT heat map from RADlogics

News | Artificial Intelligence | October 13, 2020
October 13, 2020 — Given recent high-profile cases of...